MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management

Syndexa Pharmaceuticals Expands Series B1 Financing Round with Investment by MP Healthcare Venture Management, Inc.

Guest UserDecember 30, 2011
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Pronota announces EUR 3.7 million Series C financing ; management and board changes.

Guest UserJanuary 20, 2012
Next

GenKyoTex Starts Phase 1 Trial with First in Class NOX inhibitor GKT137831. Dual NOX1/4 Inhibitor Targets Treatment of Diabetic Nephropathy.

Guest UserOctober 31, 2011

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact